adplus-dvertising
Connect with us

Business

Canada and other wealthier countries undermining efforts to ensure equitable distribution of COVID-19 vaccine, report warns – The Globe and Mail

Published

 on


A vial with a potential COVID-19 vaccine at Novavax labs, in Gaithersburg, Md., on March 20, 2020.

ANDREW CABALLERO-REYNOLDS/AFP/Getty Images

A “shopping spree” by Canada and other high-income countries to secure large quantities of COVID-19 vaccines is undermining global efforts to ensure people in developing countries aren’t pushed to the back of the line, a new report warns.

Researchers with Duke University’s Global Health Innovation Center (GHIC) analyzed the wave of announcements made in recent months by these countries to secure priority access to COVID-19 vaccine candidates in the event that the vaccines are approved for use.

The research found that, to date, these agreements with pharmaceutical companies by high-income countries and a few middle-income countries have secured access to nearly 3.8 billion doses, with options for another five billion.

Story continues below advertisement

In a report to be released Monday, the researchers warn that these one-off agreements run contrary to the commitments of Canada and more than 170 other countries that have signed on to support the COVAX Facility. COVAX is co-led by the international vaccine alliance Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization. The aim of COVAX is to ensure equitable access for all countries to a COVID-19 vaccine.

Prime Minister Justin Trudeau announced Canada’s participation in COVAX in September, pledging $220-million to procure up to 15 million vaccine doses for Canada and another $220-million to purchase doses for low-and-middle income countries.

Canada has also signed direct agreements with several pharmaceutical companies that secure access to up to 358 million doses of the various vaccine candidates. Should all of the candidates be approved for use, that would give Canada enough supply to vaccinate its population of 38 million several times over.

The Duke report says current models suggest that there won’t be enough vaccines to cover the world’s population until 2024.

While there have been other warnings regarding “vaccine nationalism,” Duke researchers say the report is the first detailed effort to quantify the number of vaccine doses that have been committed through country-level agreements and the impact this could have on low-income countries.

Andrea Taylor, the Oxford-based assistant director of programs for Duke’s GHIC and the lead researcher for the report, said other governments such as Britain and the European Union have faced sharp criticism for signing large deals with pharmaceutical companies, but Canada’s efforts haven’t received the same level of scrutiny. Ms. Taylor said Ottawa has secured “far and away” more vaccine doses per person than any other country.

“Because manufacturing capacity is limited, every direct deal that’s done by a country like Canada reduces the number of doses that are available for something like COVAX,” she said.

Story continues below advertisement

“So I think it’s interesting looking at Canada, because the population is a bit smaller than some of the other countries that have gotten a lot of flak. Their actual number of confirmed doses doesn’t fly off the charts. But when you look at it relative to population, it really does.”

The Duke news release accompanying the report states that the “shopping spree” by high-income countries is undercutting the pledges of COVAX signatories, such as Canada, the EU and Britain. The United States has not signed on to COVAX. The report found that no low-income countries have signed direct agreements with vaccine manufacturers.

The lack of vaccine-manufacturing capacity will be a major cause of delays in vaccinating the global population, the report said. Mr. Trudeau recently announced funding for Quebec biopharmaceutical company Medicago Inc. to create a production facility in Quebec City.

Ms. Taylor said that announcement shows Canada recognizes that this is an issue that needs to be addressed.

“In the last week or two, we have seen a lot more activity and investment going into manufacturing capacity and unlocking additional capacity, which is great news,” she said.

In an interview Sunday with The Globe and Mail, International Development Minister Karina Gould said she disagrees with the premise that direct vaccine procurements undermine COVAX. Ms. Gould said Canada is the second largest financial supporter of COVAX and that Ottawa is directly involved in the planning work to ensure COVAX is a success.

Story continues below advertisement

“We’ve helped set [COVAX] up right from the beginning and we are very active in helping to shape it. And we really want to see that be a success,” she said. “We understand how important that is to ultimately confront, and hopefully end, the COVID-19 pandemic.”

Know what is happening in the halls of power with the day’s top political headlines and commentary as selected by Globe editors (subscribers only). Sign up today.

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Business

Roots sees room for expansion in activewear, reports $5.2M Q2 loss and sales drop

Published

 on

 

TORONTO – Roots Corp. may have built its brand on all things comfy and cosy, but its CEO says activewear is now “really becoming a core part” of the brand.

The category, which at Roots spans leggings, tracksuits, sports bras and bike shorts, has seen such sustained double-digit growth that Meghan Roach plans to make it a key part of the business’ future.

“It’s an area … you will see us continue to expand upon,” she told analysts on a Friday call.

The Toronto-based retailer’s push into activewear has taken shape over many years and included several turns as the official designer and supplier of Team Canada’s Olympic uniform.

But consumers have had plenty of choice when it comes to workout gear and other apparel suited to their sporting needs. On top of the slew of athletic brands like Nike and Adidas, shoppers have also gravitated toward Lululemon Athletica Inc., Alo and Vuori, ramping up competition in the activewear category.

Roach feels Roots’ toehold in the category stems from the fit, feel and following its merchandise has cultivated.

“Our product really resonates with (shoppers) because you can wear it through multiple different use cases and occasions,” she said.

“We’ve been seeing customers come back again and again for some of these core products in our activewear collection.”

Her remarks came the same day as Roots revealed it lost $5.2 million in its latest quarter compared with a loss of $5.3 million in the same quarter last year.

The company said the second-quarter loss amounted to 13 cents per diluted share for the quarter ended Aug. 3, the same as a year earlier.

In presenting the results, Roach reminded analysts that the first half of the year is usually “seasonally small,” representing just 30 per cent of the company’s annual sales.

Sales for the second quarter totalled $47.7 million, down from $49.4 million in the same quarter last year.

The move lower came as direct-to-consumer sales amounted to $36.4 million, down from $37.1 million a year earlier, as comparable sales edged down 0.2 per cent.

The numbers reflect the fact that Roots continued to grapple with inventory challenges in the company’s Cooper fleece line that first cropped up in its previous quarter.

Roots recently began to use artificial intelligence to assist with daily inventory replenishments and said more tools helping with allocation will go live in the next quarter.

Beyond that time period, the company intends to keep exploring AI and renovate more of its stores.

It will also re-evaluate its design ranks.

Roots announced Friday that chief product officer Karuna Scheinfeld has stepped down.

Rather than fill the role, the company plans to hire senior level design talent with international experience in the outdoor and activewear sectors who will take on tasks previously done by the chief product officer.

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:ROOT)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Talks on today over HandyDART strike affecting vulnerable people in Metro Vancouver

Published

 on

 

VANCOUVER – Mediated talks between the union representing HandyDART workers in Metro Vancouver and its employer, Transdev, are set to resume today as a strike that has stopped most services drags into a second week.

No timeline has been set for the length of the negotiations, but Joe McCann, president of the Amalgamated Transit Union Local 1724, says they are willing to stay there as long as it takes, even if talks drag on all night.

About 600 employees of the door-to-door transit service for people unable to navigate the conventional transit system have been on strike since last Tuesday, pausing service for all but essential medical trips.

Hundreds of drivers rallied outside TransLink’s head office earlier this week, calling for the transportation provider to intervene in the dispute with Transdev, which was contracted to oversee HandyDART service.

Transdev said earlier this week that it will provide a reply to the union’s latest proposal on Thursday.

A statement from the company said it “strongly believes” that their employees deserve fair wages, and that a fair contract “must balance the needs of their employees, clients and taxpayers.”

This report by The Canadian Press was first published Sept. 12, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending